Skip to content
Recall Observatory FDA recall evidence

Drug product

Olanzapine tablets, USP, 2.5 mg, packaged in a 30-count bottle, Rx only, Mfd: By: Dr. Reddy's Laboratories Limited, Bachupally, India, NDC 55111-163-30

D-0468-2017

October 13, 2016

Class III

Product summary

Firm
Dr. Reddy's Laboratories, Inc.
Event
Event 75442
Status
Terminated
Classification
Class III
Quantity
5,904 bottles
Official record key
drug-enforcement:D-0468-2017

Official wording

Reason: Failed impurities/degradation specifications: due to out-of-specification result for the Related Substance Compound C (Impurity 6 - N-Oxide at the 18 month stability station.

Code information: C500202

Distribution pattern: US Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    out-of-specification